Unknown Company
Logistics:
Manager; Director
REMOTE
$120 - $210 /hour
6 months
10 hours/wk
This is a 1099 Consulting Opportunity
ABOUT
Clora has partnered with a preclinical-stage oncology biotech that is developing antibody drug conjugates (ADCs) and radioligand therapies for the treatment of solid tumors. They are seeking a discovery biologist to advance our tumor-selective radioligand therapy program based on the client's proprietary platform. The role will focus on optimizing tumor targeting, biodistribution, and retention while minimizing normal-tissue exposure.
RESPONSIBILITIES
- Design and oversee in vitro and in vivo studies evaluating RLT candidate binding, internalization, tumor uptake, and retention.
- Characterize the impact of antibody affinity, binding kinetics, and Fc engineering on tumor targeting and systemic clearance.
- Analyze biodistribution, imaging, and tissue radioactivity data to support lead optimization and candidate selection.
- Coordinate radiolabeling, imaging, and pharmacology studies with external CROs and radiochemistry collaborators.
- Support selection of development candidates and design of IND-enabling pharmacology studies.
IDEAL CANDIDATE
- PhD or MS in cancer biology, pharmacology, molecular biology, or related field with at least 5+ industry experience within Biotech/Biopharma/Pharma organization(s)
- Strong background in antibody biology, tumor models, and preclinical oncology pharmacology.
- Experience with radiopharmaceuticals, quantitative biodistribution, SPECT/PET imaging, or radio-labeled biologics is strongly preferred.
Discovery Biologist Consultant to Support Radioligand Therapy (RLT) Program in boston at Unknown Company
This position is listed as full time and able to be worked remotely.